| Name | (3S,4R)-4-(4-fluorophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-3-carboxylic acid |
|---|---|
| Synonyms |
1-tert-butyl (3S,4R)-4-(4-fluoro-phenyl)-piperidine-1,3-dicarboxylate
(-)-(3S,4R)-4-(4-fluoro-phenyl)-piperidine-1,3-dicarboxylic acid 1-tert-butyl ester (3S,4R)-1-(tert-Butoxycarbonyl)-4-(4-fluorophenyl)piperidine-3-carboxylic acid |
| Molecular Formula | C17H22FNO4 |
|---|---|
| Molecular Weight | 323.35900 |
| Exact Mass | 323.15300 |
| PSA | 66.84000 |
| LogP | 3.18880 |
| HS Code | 2933399090 |
|---|
|
~%
923932-21-2 |
| Literature: CONCERT PHARMACEUTICALS INC. Patent: WO2007/16431 A2, 2007 ; Location in patent: Page/Page column 56 ; WO 2007/016431 A2 |
|
~52%
923932-21-2 |
| Literature: Bachmann, Stephan; Scalone, Michelangelo; Schnider, Patrick Patent: US2007/232653 A1, 2007 ; Location in patent: Page/Page column 33 ; |
| Precursor 0 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |